loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Parenteral? Find Poly DL Lactide, Poly DL Lactide co Glycolide , Poly L Lactide offered by Nomisma Healthcare for stability, solubility & bioavailability enhancement on PharmaCompass.

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    View Presentation

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Nomisma Healthcare

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Injectable / Parenteral

    02 3Tablet

    filter clear-filterReset all filters

    PharmaCompass

    01

    Brand Name : PLLA

    PLLA

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : PLLA

    India
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    Nomisma Healthcare

    Application : Controlled & Modified Release, Parenteral

    Excipient Details : PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Ingredient(s) : Poly L Lactide

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly L Lactide

    Dosage Form : Injectable / Parenteral, Tablet

    Category : Controlled & Modified Release, Parenteral

    Brand : PLLA

    Applications : PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    02

    Brand Name : PDLLA

    PDLLA

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : PDLLA

    India
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    Nomisma Healthcare

    Application : Controlled & Modified Release, Parenteral

    Excipient Details : PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Ingredient(s) : Poly DL Lactide

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly DL Lactide

    Dosage Form : Injectable / Parenteral, Tablet

    Category : Controlled & Modified Release, Parenteral

    Brand : PDLLA

    Applications : PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    03

    Brand Name : PLGA

    PLGA

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : PLGA

    India
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    Nomisma Healthcare

    Application : Controlled & Modified Release, Parenteral

    Excipient Details : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

    Ingredient(s) : Poly DL Lactide co Glycolide

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly DL Lactide co Glycolide

    Dosage Form : Injectable / Parenteral, Tablet

    Category : Controlled & Modified Release, Parenteral

    Brand : PLGA

    Applications : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place